MENU
+Compare
BGM
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$7.25
Change
-$0.16 (-2.16%)
Capitalization
1.45B

BGM BGM Group Ltd Forecast, Technical & Fundamental Analysis

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business... Show more

BGM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BGM with price predictions
Sep 05, 2025

Momentum Indicator for BGM turns negative, indicating new downward trend

BGM saw its Momentum Indicator move below the 0 level on August 29, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 105 similar instances where the indicator turned negative. In of the 105 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for BGM moved below the 200-day moving average on August 21, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BGM entered a downward trend on August 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BGM's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for BGM just turned positive on August 18, 2025. Looking at past instances where BGM's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BGM advanced for three days, in of 161 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.987) is normal, around the industry mean (16.575). P/E Ratio (0.000) is within average values for comparable stocks, (74.307). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). BGM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (5.244) is also within normal values, averaging (42.679).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BGM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
BGM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIGOX37.180.13
+0.35%
Alger Growth & Income I-2
ACLCX8.24N/A
N/A
American Century Value C
MNOPX32.78N/A
N/A
Morgan Stanley Inst International Opp R6
FTADX56.45N/A
N/A
Fidelity Advisor International Discv M
NAEFX72.32N/A
N/A
New Alternatives Investor

BGM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BGM has been closely correlated with APNHF. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BGM jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGM
1D Price
Change %
BGM100%
-2.16%
APNHF - BGM
73%
Closely correlated
N/A
MSTH - BGM
28%
Poorly correlated
N/A
SXTC - BGM
25%
Poorly correlated
+16.67%
CPIX - BGM
21%
Poorly correlated
-9.56%
YCBD - BGM
21%
Poorly correlated
+1.44%
More

Groups containing BGM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGM
1D Price
Change %
BGM100%
-2.16%
Pharmaceuticals: Generic
industry (223 stocks)
7%
Poorly correlated
+2.48%